chr1-103025905-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001854.4(COL11A1):​c.898-292A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0653 in 1,612,598 control chromosomes in the GnomAD database, including 3,701 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 532 hom., cov: 32)
Exomes 𝑓: 0.064 ( 3169 hom. )

Consequence

COL11A1
NM_001854.4 intron

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0480

Publications

18 publications found
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
COL11A1 Gene-Disease associations (from GenCC):
  • Marshall syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • Stickler syndrome type 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet, Genomics England PanelApp
  • fibrochondrogenesis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal dominant 37
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017307997).
BP6
Variant 1-103025905-T-G is Benign according to our data. Variant chr1-103025905-T-G is described in ClinVar as [Benign]. Clinvar id is 668356.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.111 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A1NM_001854.4 linkc.898-292A>C intron_variant Intron 6 of 66 ENST00000370096.9 NP_001845.3 P12107-1Q59HB5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkc.898-292A>C intron_variant Intron 6 of 66 1 NM_001854.4 ENSP00000359114.3 P12107-1

Frequencies

GnomAD3 genomes
AF:
0.0789
AC:
12002
AN:
152066
Hom.:
529
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.113
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0658
Gnomad ASJ
AF:
0.0729
Gnomad EAS
AF:
0.0724
Gnomad SAS
AF:
0.0723
Gnomad FIN
AF:
0.104
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.0591
Gnomad OTH
AF:
0.0794
GnomAD2 exomes
AF:
0.0706
AC:
17714
AN:
250762
AF XY:
0.0704
show subpopulations
Gnomad AFR exome
AF:
0.115
Gnomad AMR exome
AF:
0.0546
Gnomad ASJ exome
AF:
0.0821
Gnomad EAS exome
AF:
0.0798
Gnomad FIN exome
AF:
0.101
Gnomad NFE exome
AF:
0.0615
Gnomad OTH exome
AF:
0.0708
GnomAD4 exome
AF:
0.0638
AC:
93242
AN:
1460414
Hom.:
3169
Cov.:
31
AF XY:
0.0638
AC XY:
46379
AN XY:
726624
show subpopulations
African (AFR)
AF:
0.121
AC:
4064
AN:
33452
American (AMR)
AF:
0.0556
AC:
2486
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0796
AC:
2079
AN:
26128
East Asian (EAS)
AF:
0.0641
AC:
2543
AN:
39672
South Asian (SAS)
AF:
0.0679
AC:
5852
AN:
86248
European-Finnish (FIN)
AF:
0.0990
AC:
5225
AN:
52800
Middle Eastern (MID)
AF:
0.0944
AC:
544
AN:
5760
European-Non Finnish (NFE)
AF:
0.0596
AC:
66185
AN:
1111294
Other (OTH)
AF:
0.0706
AC:
4264
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4590
9179
13769
18358
22948
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2570
5140
7710
10280
12850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0791
AC:
12033
AN:
152184
Hom.:
532
Cov.:
32
AF XY:
0.0804
AC XY:
5982
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.114
AC:
4718
AN:
41520
American (AMR)
AF:
0.0658
AC:
1004
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.0729
AC:
253
AN:
3470
East Asian (EAS)
AF:
0.0725
AC:
375
AN:
5170
South Asian (SAS)
AF:
0.0726
AC:
350
AN:
4824
European-Finnish (FIN)
AF:
0.104
AC:
1099
AN:
10606
Middle Eastern (MID)
AF:
0.146
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
0.0591
AC:
4020
AN:
68008
Other (OTH)
AF:
0.0791
AC:
167
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
541
1081
1622
2162
2703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0661
Hom.:
1006
Bravo
AF:
0.0793
TwinsUK
AF:
0.0547
AC:
203
ALSPAC
AF:
0.0586
AC:
226
ESP6500AA
AF:
0.112
AC:
493
ESP6500EA
AF:
0.0636
AC:
547
ExAC
AF:
0.0711
AC:
8635
Asia WGS
AF:
0.0680
AC:
237
AN:
3478
EpiCase
AF:
0.0643
EpiControl
AF:
0.0634

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
15
DANN
Benign
0.95
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.16
T;T;T
MetaRNN
Benign
0.0017
T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
0.048
PROVEAN
Benign
-0.88
N;.;N
REVEL
Benign
0.094
Sift
Benign
0.45
T;.;T
Sift4G
Benign
0.40
T;.;.
Polyphen
0.0
B;.;.
Vest4
0.044
MutPred
0.34
Loss of methylation at K276 (P = 6e-04);.;Loss of methylation at K276 (P = 6e-04);
ClinPred
0.0097
T
GERP RS
0.88
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12731843; hg19: chr1-103491461; COSMIC: COSV62181630; COSMIC: COSV62181630; API